arXiv:2609.09510v1 Announce Type: cross
Abstract: High-risk non-muscle-invasive bladder cancer (HR-NMIBC) carries substantial risks of recurrence and progression, while current clinical risk stratifi...
By Catherine Chia, Tongjie Wang, Robert Spaans, Maryam Mohammadlou, Farbod Khoraminia, J. Alberto Nakauma-Gonz\'alez, Adam Kowalewski, Parandzem Khachatryan, Domingos Oliveira, Khrystyna Faryna, CHIMERA Challenge Consortium, Marlies Wakkee, Sita Vermeulen, Tahlita Zuiverloon, Nadieh Khalili
arXiv:2605. 25050v2 Announce Type: replace-cross Abstract: Integrating multimodal datasets in clinical oncology is frequently hindered by high dimensionality and blockwise missingness, where entire data sources are unavailable for specific patient subsets.
By Mohamed Boussena, Florence Monville, Jacques Fieschi-Meric, Frederic Vely, Pierre Milpied, Julien Mazieres, Maurice Perol, Eric Vivier, Laurent Greillier, Fabrice Barlesi, Sebastien Benzekry
Active surveillance (AS) is the preferred strategy for favorable-risk prostate cancer, yet current protocols rely on scheduled repeat biopsies, most of which reveal no progression and are unnecessary. Existing risk-stratification tools operate on single time-point imaging or depend on explicit lesion segmentation, limiting their ability to capture longitudinal change and excluding patients without an MRI-visible lesion.
The paper introduces a multimodal dataset for survival prediction in resected pancreatic ductal adenocarcinoma, comprising 302 patients, 446 H&E whole-slide images, clinicopathological variables, targeted sequencing data for 154 patients, and overall survival outcomes. The authors evaluated fourteen survival‑prediction models, finding that a Ridge Cox regression on numeric clinicopathological variables achieved the highest concordance (≈0.65), while multimodal fusion of image and molecular data reached 0.619. These benchmarks provide a foundation for future research and external validation using this pancreas‑specific dataset.
By Anh-Tien Nguyen, Mawuko Tettey, Jacqueline Michelle Metsch, Teresa Zimmer, Niklas Ullrich, Mario Duker, Sandra Rungeling, Kirsten Reuter-Jessen, Tessa Rosenthal, Lena-Christin Conradi, Michael Ghadimi, Alexander Konig, Elisabeth Hessmann, Volker Ellenrieder, Philipp Strobel, Hanibal Bohnenberger, Anne-Christin Hauschild
arXiv:2606. 17115v1 Announce Type: cross Abstract: Foundation models (FMs) have emerged as powerful representation extractors for medical data, yet their generalizability to datasets under distribution shift remains underexplored.
By Jingyu Hu, Giuseppe Tripodi, Reed Naidoo, Sarah F. McGough, Tapabrata Chakraborti
arXiv:2607. 06919v1 Announce Type: cross Abstract: Artificial intelligence (AI) analysis of micro-ultrasound ($\mu$US) has shown promise for prostate cancer (PCa) detection.
By Paul F. R. Wilson, Mohamed Harmanani, Zhuoxin Guo, Obed K. Dzikunu, Hannes Cash, Adam Kinnaird, Brian Wodlinger, Purang Abolmaesumi, Parvin Mousavi
arXiv:2607. 25933v1 Announce Type: cross Abstract: Clinical diagnostic evaluation should not only assess whether models can provide correct diagnoses, but also reflect the realities of clinical practice, including progressive disclosure of multimodal information, dynamic updating of diagnostic hypotheses, and continuous refinement of clinical reasoning.
By Rui Yang, Weihao Xuan, Yi Lin, Zhuhan Bao, Jonathan Chong Kai Liew, Matthew Yu Heng Wong, Nicol\'as Lescano, Nikita R. Paripati, Emily Ling-Lin Pai, Jiarui Liu, Heli Qi, Heng-Jui Chang, Benny Kai Guo Loo, Huitao Li, Kunyu Yu, Yufan Wang, Chuan Hong, Shijian Lu, Douglas Teodoro, Naoto Yokoya, Ross Koppel, Mona Diab, Hua Xu, David W. Bates, Nan Liu, Yifan Peng
arXiv:2608. 16233v1 Announce Type: cross Abstract: Missing or degraded sequences can limit prostate multiparametric MRI.
By Siyuan Ma, Liang He, Mengying Zhu, Yi Chai, Mengyao Lyu, Haowei Wang, Qizhen Lan, HaoBo Sun, Qixin Zhang, Jingli Chen, Xiaobing Wei, Jiaming Liu, Guiqin Liu, Qianwen Zhang, Yang Liu, Dacheng Tao, Guangyu Wu
The paper introduces a Mixture of Multicenter Experts (MoME) framework that leverages diverse clinical strategies to reduce bias in medical AI without sharing data across institutions. MoME integrates specialized expertise from multiple centers, improving generalizability and adaptability of a multimodal target volume delineation model for prostate cancer radiotherapy. The model, trained with few-shot imaging and clinical notes, outperformed baselines, especially in high inter‑center variability or limited data scenarios, and allows local customization without cross‑institutional data exchange.
By Yujin Oh, Sangjoon Park, Xiang Li, Pengfei Jin, Yi Wang, Jonathan Paly, Jason Efstathiou, Annie Chan, Jun Won Kim, Hwa Kyung Byun, Ik Jae Lee, Jaeho Cho, Chan Woo Wee, Peng Shu, Peilong Wang, Caiwen Jiang, Nathan Yu, Jason Holmes, Jong Chul Ye, Quanzheng Li, Wei Liu, Woong Sub Koom, Jin Sung Kim, Kyungsang Kim
arXiv:2510.06113v2 Announce Type: replace
Abstract: Survival analysis plays a vital role in making clinical decisions. However, the models currently in use are often difficult to interpret, which red...
By Shuo Jiang, Zhuwen Chen, Liaoman Xu, Yanming Zhu, Changmiao Wang, Jiong Zhang, Feiwei Qin, Yifei Chen, Zhu Zhu
Objectives: To characterize residual false positives in prostate MRI detection, and to evaluate a lightweight post-hoc refinement head for case-level specificity. Materials and Methods: This retrospective study used PI-CAI (5-fold cross-validation) and Prostate158 (n=158; external).
arXiv:2607. 07673v1 Announce Type: cross Abstract: Medicine is inherently multimodal, requiring clinicians to synthesize information across diverse data streams.
By Hyunjae Kim, Dain Kim, Pan Xiao, Serina S. Applebaum, Younjoon Chung, Xuguang Ai, Yu Yin, Roy Jiang, Yuexi Du, Yawen Wei, Yiming Kong, Tuo Guo, Zhiyuan Cao, Mengmeng Du, Yuelei Fu, Yan Hu, Rui Shi, Gui Yang, Kevin W. Jin, Yuntian Liu, Yuxuan Tian, Jonathan Marquez, Zhen Chen, Sheng Zhang, Hoifung Poon, Hua Xu, Jaewoo Kang, Qingyu Chen